P-32 An Investigation into the Occular Effects of Chemotherapy in Breast Cancer Patients Ages 35–65 at the Georgetown Public Hospital Oncology Department Georgetown Public Hospital, Guyana
Author(s):
Fausett. T, Alexander E, Gibson. T, Wilkinson. G, Yarde I, Ang G, Villareal M, Gooding L and G Joseph and Cummings E
Year of Presentation:
2022
Objective: Investigate the ocular effects of chemotherapy
in breast cancer patients
Design and Methods: A cross-sectional study design was done involving 112 previously diagnosed breast cancer patients, aged 35 to 65 that were divided into 3 groups (Never received Chemotherapy, Currently Chemotherapy and Finished Chemotherapy. A questionnaire was adminis- 49 tered to the study group in addition to being subjected to an eye test. The main questions included, chemotherapy status, stages of cancer, presence of ocular issues and family history.
Results: Sixty-five percentage (65%) of patients had ocular effects from chemotherapy which was significant .100% of the patients who were currently on chemotherapy had experience ocular effects. The effects of the drugs on the patient’s vision increased by 83% while those who completed chemotherapy they ocular problem decreased by 87.5%. Blurred vision along with severe light sensitivity was the most common ocular effect caused by chemotherapy as it was observed in 21% of total patients.
Conclusion: Prior studies and research in the literature review relatively shown evident that the effects of chemotherapy drugs on Breast cancer patient’s vision was significant, which correlates to this study. 100% of patients who were currently on chemotherapy experienced one or more ocular effects in their vision.